Corcept Therapeutics Stock Forward View - Relative Strength Index
| CORT Stock | USD 33.74 0.20 0.60% |
Momentum
Sell Stretched
Oversold | Overbought |
Quarterly Earnings Growth -0.22 | EPS Estimate Next Quarter -0.05 | EPS Estimate Current Year 0.384 | EPS Estimate Next Year 1.608 | Wall Street Target Price 65.4 |
This view relates Corcept Therapeutics' headline activity to recent price response context. Options and short interest provide context for sentiment around Corcept Therapeutics in this section.
Short Interest Tracking - Corcept Therapeutics
Corcept Therapeutics short interest relative to sector peers provides additional context. If Corcept Therapeutics' short interest is significantly higher than competitors. the market may perceive company-specific risks that warrant investigation.
200 Day MA 66.1149 | Short Percent 0.1578 | Short Ratio 5.99 | Shares Short Prior Month 10 M | 50 Day MA 38.4718 |
RSI Oscillator - Corcept
Attention-to-Price Pattern - Corcept Therapeutics
The relationship between Corcept Therapeutics' news sentiment and price action reveals how efficiently the market processes new information about Corcept. Persistent sentiment-price gaps create exploitable opportunities for disciplined investors.
Investors who systematically buy Corcept Therapeutics when sentiment is deeply negative and sell when it is excessively positive have historically captured mean-reversion returns not available to purely fundamental or technical investors.
Corcept Therapeutics Implied Volatility | 0.83 |
Implied volatility in Corcept Therapeutics' options does not predict direction - it measures magnitude. An investor expecting a large move in Corcept Therapeutics stock in either direction may benefit from strategies that profit from volatility expansion.
Corcept Therapeutics after-hype prediction price | $ 32.71 |
The sentiment view is a companion to forecasting, technical studies, analyst estimates, and earnings trends.
Cross-verify projections for Corcept Therapeutics using Historical Fundamental Analysis of Corcept Therapeutics. The view supplies historical context for the projection discussion.Rule 16 Reference for the current Corcept contract - Performance Context
Based on Rule 16, the market-implied daily move for 2026-05-15 options is about 0.0519%. This context is informational: with Corcept Therapeutics near $ 33.74, the daily move estimate is $ 0.0175 .
Open Interest Map for Corcept Options 2026-05-15
The open interest measure summarizes active contracts for Corcept Therapeutics and can be paired with trend context.
Corcept Therapeutics Additional Predictive Modules
Most predictive techniques to examine Corcept price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Corcept using various technical indicators. When you analyze Corcept charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 29.03 | 29.03 |
| Check Corcept Therapeutics Volatility | Backtest Corcept Therapeutics | Information Ratio |
Corcept Therapeutics Trading Date Momentum
| On March 13 2026 Corcept Therapeutics Incorporated was traded for 33.74 at the closing time. The top price for the day was 34.27 and the lowest listed price was 33.00 . There was no trading activity during the period 0.0. Lack of trading volume on March 13, 2026 did not affect price variability. The overall trading delta against the current closing price is -0.80% . |
| Compare Corcept Therapeutics to competition |
Other Forecasting Options for Corcept Therapeutics
Understanding Corcept Therapeutics' price movement is a prerequisite for any investor considering Corcept as a position. Corcept Stock price charts are frequently cluttered with noise that can interfere with accurate interpretation.Corcept Therapeutics Related Equities
The following equities are related to Corcept Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Corcept Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Corcept Therapeutics Market Strength Events
For traders and investors in Corcept Therapeutics Incorporated, market strength indicators offer a quantitative framework for evaluating the stock's responsiveness to market conditions. These tools help identify when trading Corcept Therapeutics shares is most likely to generate favorable returns.
Corcept Therapeutics Risk Indicators
Analyzing Corcept Therapeutics' risk indicators provides a critical input for price forecasting and investment risk management. By quantifying the risk in Corcept Therapeutics' investment, investors can make more informed decisions about their exposure and hedging strategies.
| Mean Deviation | 3.84 | |||
| Standard Deviation | 7.57 | |||
| Variance | 57.23 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Corcept Therapeutics
Coverage intensity for Corcept Therapeutics Incorporated matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Corcept Therapeutics Short Properties
Short sentiment tied to Corcept Therapeutics Incorporated matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 120 M | |
| Cash And Short Term Investments | 372.2 M |
Additional Tools for Corcept Stock Analysis
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |